| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 807.52B | 801.75B | 818.76B | 876.08B | 762.93B | 655.53B |
| Gross Profit | 356.75B | 357.14B | 346.46B | 393.88B | 346.83B | 298.35B |
| EBITDA | 81.46B | 62.45B | 65.77B | 125.00B | 110.08B | 87.84B |
| Net Income | 32.71B | 16.27B | 8.11B | 73.86B | 61.40B | 43.31B |
Balance Sheet | ||||||
| Total Assets | 1.37T | 1.36T | 1.35T | 998.16B | 930.63B | 820.38B |
| Cash, Cash Equivalents and Short-Term Investments | 156.91B | 149.02B | 143.09B | 105.28B | 155.48B | 250.75B |
| Total Debt | 210.35B | 157.12B | 172.76B | 45.37B | 60.12B | 38.89B |
| Total Liabilities | 429.37B | 427.36B | 403.74B | 266.93B | 262.66B | 211.02B |
| Stockholders Equity | 776.87B | 771.88B | 786.69B | 728.47B | 665.23B | 606.86B |
Cash Flow | ||||||
| Free Cash Flow | 13.86B | 6.79B | -503.00M | 8.44B | 34.07B | 67.17B |
| Operating Cash Flow | 63.35B | 55.78B | 44.88B | 53.46B | 67.43B | 93.83B |
| Investing Cash Flow | -50.46B | -47.89B | -107.10B | -55.53B | -150.16B | -14.79B |
| Financing Cash Flow | -9.43B | -4.61B | 85.99B | -58.76B | -29.60B | -20.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $720.96B | 25.82 | 13.68% | 1.09% | 21.48% | 65.56% | |
76 Outperform | $1.27T | 22.38 | 8.05% | 1.61% | 0.96% | 3.22% | |
75 Outperform | $1.23T | 23.58 | 10.84% | 1.56% | 3.92% | 9.99% | |
74 Outperform | $553.22B | 37.95 | 4.19% | 2.37% | 3.97% | -41.79% | |
72 Outperform | $698.52B | 23.17 | 8.09% | 2.37% | 11.18% | -0.75% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $875.30B | 26.77 | 3.60% | 2.45% | 3.51% | ― |
OMRON Corporation, a leading player in the industrial automation and healthcare sectors, has released its financial results for the first half of the fiscal year ending March 31, 2026, showcasing its diverse business operations across various sectors.
OMRON Corporation has announced the approval of its ‘Medium-Term Roadmap SF 2nd Stage,’ a strategic plan set to guide the company from FY2026 to FY2030. This roadmap follows the completion of the ‘NEXT 2025’ Structural Reform Program and aims to transition OMRON’s business portfolio towards sustainable, profit-driven growth, thereby increasing corporate value.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4900.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
OMRON Corporation reported an increase in consolidated revenue for the first half of FY2025, although profits declined due to lower gross profit margins and growth investments. The Industrial Automation Business (IAB) saw revenue and profit growth, driven by recovery in the customer base and strong demand in key industries. The Healthcare Business (HCB) initially experienced a decline but rebounded in the second quarter. The company revised its full-year forecasts, expecting higher revenue and profit, and maintained its dividend guidance. Structural reforms continue to support sales growth, aligning with the company’s strategic plan.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4900.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
OMRON Corporation announced the approval of an interim dividend and a revision of the year-end dividend forecast for the fiscal year ending March 31, 2026. The interim and year-end dividends are set at 52.00 yen per share, maintaining the full-year dividend forecast at 104.00 yen. This decision aligns with OMRON’s cash allocation and shareholder return policies during its restructuring period, emphasizing investments in long-term value creation and stable shareholder returns.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4900.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
OMRON Corporation reported its consolidated financial results for the first half of the fiscal year ending March 31, 2026, showing a 5% increase in net sales compared to the same period last year. Despite the rise in sales, operating income decreased by 7.8%, reflecting challenges in operational efficiency. The company also announced an interim dividend of 52 yen per share, maintaining its annual dividend forecast, indicating a stable return for shareholders.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4900.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
OMRON Corporation’s Board of Directors has initiated discussions to spin off its Device & Module Solutions Business (DMB) by April 1, 2026. This move aims to establish an independent management structure for DMB to enhance agility, cost-competitiveness, and investment in new product development, amidst growing market demand and competitive pressures.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen4232.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.